The global pulsed field ablation market was valued at USD 144.82 Million in 2024, driven by the rising prevalence of atrial fibrillation and technological advancements across the globe. The market is anticipated to grow at a CAGR of 24.20% during the forecast period of 2025-2034, with the values likely to reach USD 1264.87 Million by 2034.
Base Year
Historical Year
Forecast Year
The market is projected to witness significant growth due to increasing demand for minimally invasive cardiac ablation procedures, driven by rising atrial fibrillation cases and advancements in energy-based ablation technologies.
Emerging technological innovations and extensive clinical trials are fostering the adoption of pulsed field ablation systems, particularly as safer and more precise alternatives to traditional thermal ablation methods.
Expanding healthcare infrastructure and growing awareness about atrial fibrillation treatment options are expected to drive market growth, especially in developing regions with increasing investment in advanced medical devices.
Pulsed field ablation (PFA) is a cutting-edge cardiac treatment technique that uses short, high-voltage electrical pulses to selectively ablate cardiac tissue. Unlike traditional thermal methods, PFA leverages the process of electroporation to disrupt abnormal heart rhythms while sparing surrounding tissues. It offers enhanced safety, precision, and efficiency, making it a promising solution for treating atrial fibrillation and other arrhythmias.
Launch of Minimally Invasive Products to Boost Market Value
The increasing demand for minimally invasive treatments and advancements in hybrid ablation technologies are key drivers of the market. For instance, in October 2024, Medtronic plc received FDA approval for the Affera Mapping and Ablation System with the Sphere-9 Catheter. This system combines pulsed field and radiofrequency ablation technologies for persistent atrial fibrillation (AFib) and atrial flutter treatments, offering physicians unparalleled flexibility. With Medtronic’s two FDA-approved PFA systems, the company is set to bolster the adoption of PFA technologies, driving global market expansion during the forecast period by meeting diverse physician and patient needs.
Advent of Advanced Devices to Boost Pulsed Field Ablation Market Demand
Growing investments in advanced imaging and ablation solutions are shaping the market. For instance, in October 2024, Boston Scientific secured FDA approval for its FARAWAVE NAV Ablation Catheter and FARAVIEW Software, designed to work seamlessly with the FARAPULSE PFA System. The new technologies enable precise navigation and enhance cardiac visualisation during ablation procedures. By integrating these innovations with Boston Scientific’s existing mapping technology, the company is positioned to enhance procedural efficacy, improve patient outcomes and contribute to the growth of the market in the forecast period.
The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Components
Market Breakup by Indication
Market Breakup by End User
Market Breakup by Region
Market Segmentation Based on Component to Witness Growth
The market is categorised into catheters and generators based on components. The catheter segment is poised to lead the market during the forecast period. Catheters are the primary tools for delivering pulsed electric fields directly to cardiac tissue, making them indispensable in ablation procedures. With ongoing advancements in catheter design, including improved navigation and precision, demand continues to rise. Their widespread adoption across inpatient and outpatient facilities, particularly for atrial fibrillation treatment, underscores their crucial role in the market.
North America holds the largest market share driven by its robust healthcare infrastructure and strong presence of key industry players. The region benefits from high adoption rates of innovative technologies, supported by extensive clinical trials and regulatory approvals. Additionally, the increasing prevalence of atrial fibrillation, coupled with growing investments in research and development, solidifies its leadership. Favourable reimbursement policies further encourage the use of advanced ablation techniques in this market.
The key features of the market report comprise patent analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Medtronic plc is a global medical technology company headquartered in Dublin, Ireland, established in 1949. Medtronic offers the PulseSelect PFA system, approved in the U.S. for treating paroxysmal and persistent atrial fibrillation (AF). This system aims to enhance safety and precision in AF treatment.
Boston Scientific is a U.S.-based medical device manufacturer founded in 1979, with headquarters in Marlborough, Massachusetts. Boston Scientific provides the FARAPULSE PFA System, which has been used in over 125,000 patients worldwide. This system focuses on selectively ablating heart tissue to reduce the risk of damage to surrounding areas.
Johnson & Johnson, established in 1886 and headquartered in New Brunswick, New Jersey, is a multinational corporation known for its medical devices, pharmaceuticals, and consumer health products. Johnson & Johnson offers the Varipulse system, approved by the U.S. FDA for treating drug-resistant paroxysmal atrial fibrillation. This system integrates with their Carto mapping technology to enhance procedural efficiency.
Abbott Laboratories, founded in 1888 and based in Abbott Park, Illinois, is a global healthcare company specializing in medical devices, diagnostics, nutrition, and branded generic pharmaceuticals. In the PFA field, Abbott has initiated human trials for its pulsed field ablation system aimed at treating atrial fibrillation, marking its entry into this emerging market.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include Acutus Medical, CathVision, Adagio Medical, Atricure, EP Solutions, and Pulse Biosciences.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2024 |
| Historical Period | 2018-2024 |
| Forecast Period | 2025-2034 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Components |
|
| Breakup by Indication |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share